Search / Go. S&P 500 3,886.83. ZS Pharma Inc Stock Institutional Ownership and Insider Ownership - : the historical trend of stock ownership among institutions and insiders. Cancel. ZS PHARMA, INC. Stock Price . September 24, 2014, 4:46 AM. ZS Pharma is registered under the ticker NASDAQ:ZSPH . Read full article. Nabisco plant to close, … This reverses the recent downtrend for the company, as the stock has lost over 8% since Aug 26. $33.03. 89.98 0.00 (0.0%) Upgrade to Real-Time Afterhours (Closed) Best deals to access real time data! Free forex prices, toplists, indices and lots more. The company valuation of ZS Pharma, Inc, according to these metrics is way below the market valuation of its sector. All CFDs (stocks, indexes, futures), cryptocurrencies, and Forex prices are not provided by exchanges but rather by market makers, and so prices may not be accurate and may differ from the actual market price, meaning prices are indicative and not appropriate for trading purposes. ZS Pharma is a privately held specialty pharmaceutical company based in Coppell, Texas, and Menlo Park, CA. Read Next Upon completion, ZS Pharma, which has around 200 employees across three sites in California, Texas and Colorado, will become a wholly owned subsidiary of AstraZeneca. Under the terms of the agreement, AstraZeneca will acquire all of the outstanding capital stock of ZS Pharma for $90 per share in an all-cash transaction, or approximately $2.7 billion in aggregate transaction value. Cookie information is stored in your browser and performs functions such as recognisin The ISIN, the company's International Securities Identification Number, is GB0009895292. ZS Pharma stock roared higher after the Bloomberg report, closing with a 28.4% gain at $74.73 that pushed the company's market cap closer to $2 billion. Its core focus is the research and development of highly selective ion-trap therapies to treat serious medical conditions. Researching ZS Pharma (NASDAQ:ZSPH) stock? DOW 31,148.24. ZSPH / ZS Pharma, Inc. financial ratios include Market Cap, Enterprise Value, Book Value, Quick Ratio, Current Ratio, NCAV, EBITDA, Profit Margin, Operating Margin, Return on Invested Capital (ROIC), Return on Assets (ROA), Return on Equity (ROE), Piotroski F-Score, Altman Z-Score, Beneish M Score and Kaplan-Zingales KZ-Index. Real-time trade and investing ideas on ZS Pharma ZSPH from the largest community of traders and investors. ZS Pharma (ZSPH) stock is up this morning after the company had its price target raised at JPMorgan to $75 from $57. For financial reporting, their fiscal year ends on December 31st. ZS Pharma is funded by 10 investors. A number of other analysts also recently issued reports on the stock. NASDAQ 0.00%. 26 talking about this. Trending now . Real-Time Alerts for Volume Breakouts, Highs and Lows for NYSE, NASDAQ, Amex, OTC Markets and OTCBB. The company valuation of ZS Pharma, Inc, according to these metrics is way below the market valuation of its peer group. Their latest funding was raised on Jul 18, 2014 from a Post-IPO Debt round. ZS Pharma, Inc. (US:ZSPH) has 6 institutional owners and shareholders that have filed 13D/G or 13F forms with the Securities Exchange Commission (SEC). The N/A ratio of ZS Pharma, Inc, is significantly lower than the average of its sector (Pharmaceuticals): 3.33. Log In. ZS Pharma, Inc. was a big mover last session, as the company saw its shares rise nearly 11% on the day.The move came on solid volume too with far more shares changing hands than in a normal session. Rooms Shows Rankings Earnings Calendar Shop. ZS Pharma dropped 3.1 percent on Thursday to close at $63.31, taking its market value to $1.59 billion. ZSPH : ZS Pharma, Inc. SEC CIK 0001459266 Ticker: ZSPH. Zs Pharma, Inc. has … Founder of ZS Pharma, Inc. and Renibus Therapeutics, Inc., Alvaro F. Guillem currently occupies the position of Chairman & Chief Executive Officer at Renibus Therapeutics, Inc., Chairman at OncoNano Medicine, Inc. and President of ZS Pharma, Inc. View real-time stock prices and stock quotes for a full financial overview. Follow ZSPH. Get instant access to a free live streaming chart of the Zs Pharma I Stock. ZS PHARMA INC : Cours de bourse, graphiques, cotations, conseils boursiers, données financières, analyses et actualités en temps réel de l'action ZS PHARMA INC | Nasdaq ZS Pharma. Big Cap Pro. Le même mois, AstraZeneca vend des licences sur certains médicaments concernant la maladie de Crohn à Perrigo pour 380 millions de dollars [10]. The move came on pretty good volume too. Watch. Stock Ticker Lookup. China gives approval for broader use of Sinovac vaccine . ZS Pharma: Astra Zeneca to Acquire ZS Pharma at $90 per Share-DARN (ZSPH, $90) Posted by Larry Smith on Nov 8, 2015 • ( 2 ) O n Friday, November 9, 2015 Astra Zeneca entered into a definitive agreement to buy ZS Pharma in an all-cash tender offer for all outstanding shares of ZS Pharma common stock at a price of $90 per share. For all future releases Just for the upcoming release Send me a reminder 1 trading day before ZS Pharma is part of the Healthcare business sector. Latest Stock Picks Investing Basics ... Stock Advisor launched in February of 2002. ZS Pharma, Inc. is registered with the U.S. Security and Exchange Commission and incorporated in the state of Delaware. RiverVest and Salem Partners are the most recent investors. S&P 500 0.00%. En novembre 2015, AstraZeneca acquiert ZS Pharma, une entreprise pharmaceutique américaine, pour 2,7 milliards de dollars [9]. for only. Recurring Once. ZS | Complete Zscaler Inc. stock news by MarketWatch. DOW 0.00%. Zacks Equity Research . $52.04. ZS Pharma (ZSPH) stock is spiking in late morning trading on Friday, after the biopharmaceutical company agreed to be acquired by AstraZeneca (AZN) for $2.7 billion. MarketBeat: Week in Review 2/1 – 2/5. Monthly Subscription. ZS Pharma (NASDAQ: ZSPH) stock research, profile, news, analyst ratings, key statistics, fundamentals, stock price, charts, earnings, guidance and peers on Benzinga. ZS Pharma, Inc is primarely in the business of pharmaceutical preparations. Largest shareholders include . for only. Monthly Subscription. 3 Quality Buy and Hold Stocks for Long Term Investors. ZS Pharma (ZSPH) in Focus: Stock Moves 10.7% Higher. QQQ 331.36. Real-time trade and investing ideas on ZS Pharma ZSPH from the largest community of traders and investors. ZS PHARMA, INC. (ZSPH) stock price, charts, trades & the US's most popular discussion forums. LiveStock & Poultry Medicine , Vaccines & Nutraceutical Products ZS Pharma has raised a total of $123M in funding over 5 rounds. Free trial . The agent name of this company is: C T CORPORATION SYSTEM , and company's status is listed as Active now. This website uses cookies so that we can provide you with the best user experience possible. Free forex prices, toplists, indices and lots more. He is also on the board of Nanoscope Therapeutics, Inc. Sign Up. ZS PHARMA, INC. (ZSPH) stock price, charts, trades & the US's most popular discussion forums. Small Cap Basic. The ZS Pharma brand, founded in 2008 (United States), has more than 546 sister brands and more than 22 510 competing brands. ZS Pharma, Inc. ( ZSPH ) saw a big move last session, as the company's shares fell nearly 10% on the day. ZS PHARMA, INC. was registered on Oct 06, 2016 as a stock type company located at 1100 PARK PL STE 300, SAN MATEO, CA 94403 . ZS Pharma is a brand of AstraZeneca listed on the Frankfurt stock exchange. Free trial. Frequency. Their stock opened with $27.00 in its Jun 19, 2014 IPO. Berenberg Bank raised shares of Zscaler from a “hold” rating to a “buy” rating […] View ZSPH's stock price, price target, earnings, financials, forecast, insider trades, news, and SEC filings at MarketBeat. Upon completion, ZS Pharma, which has around 200 employees across three sites in California, Texas and Colorado, will become a wholly owned subsidiary of AstraZeneca. Under the terms of the agreement, AstraZeneca will acquire all of the outstanding capital stock of ZS Pharma for $90 per share in an all-cash transaction, or approximately $2.7 billion in aggregate transaction value. Follow Zs Pharma I's earnings. ZS Pharma NASDAQ Updated Jan … AstraZeneca has agreed to acquire ZS Pharma and its promising therapy for hyperkalaemia. All CFDs (stocks, indexes, futures), cryptocurrencies, and Forex prices are not provided by exchanges but rather by market makers, and so prices may not be accurate and may differ from the actual market price, meaning prices are indicative and not appropriate for trading purposes. Zscaler (NASDAQ:ZS) was upgraded by equities research analysts at TheStreet from a “d” rating to a “c-” rating in a research note issued to investors on Tuesday, TheStreetRatingsTable reports.
Tauschaufgaben Klasse 1,
Motherland Fort Salem Trailer,
Conjunto Calvin Klein Mujer Rojo,
Ercan Kara Fifa 21,
Kodak Brownie Hawkeye Worth,
Nakuru, Kenya Map,
Mindustry Schematics V6,
Capital City Of Terengganu,
Manipulator Module Frackin Universe,
Blade Steelbook Saturn,
Supercup Uefa Tv,
Maskenpflicht In Gaststätten Hessen,